NEW YORK (GenomeWeb News) - Third Wave Technologies said today that it has secured a five-year, $25 million line of credit with healthcare investment company Deerfield Management.
 
Third Wave said it may use the extra capital to market its human papillomavirus tests.
 
The company said any funds it borrows under the facility will have a 7.75 percent interest rate, and an annual two percent non-usage fee will be assessed on the amount the company does not draw.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.